References

Perioperative Chemotherapy With Fluorouracil Plus Leucovorin, Oxaliplatin, and Docetaxel Versus Fluorouracil or Capecitabine Plus Cisplatin and Epirubicin for Locally Advanced, Resectable Gastric or Gastro‐Oesophageal Junction Adenocarcinoma (FLOT4): A Randomised, Phase 2/3 Trial

10.1016/s0140-6736(18)32557-1 · 2019 · External reference

PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S‐1 Plus Surgery and Adjuvant S‐1 Versus Surgery and Adjuvant S‐1 for Resectable Advanced Gastric Cancer

10.1200/jco.20.02914 · 2021 · External reference

Perioperative or Postoperative Adjuvant Oxaliplatin With S‐1 Versus Adjuvant Oxaliplatin With Capecitabine in Patients With Locally Advanced Gastric or Gastro‐Oesophageal Junction Adenocarcinoma Undergoing D2 Gastrectomy (RESOLVE): An Open‐Label, Superiority and Non‐Inferiority, Phase 3 Randomised Controlled Trial

10.1016/s1470-2045(21)00297-7 · 2021 · External reference

Adjuvant Chemotherapy for Gastric Cancer With S‐1, an Oral Fluoropyrimidine

10.1056/nejmoa072252 · 2007 · External reference

A Prospective Multi‐Institutional Validity Study to Evaluate the Accuracy of Clinical Diagnosis of Pathological Stage III Gastric Cancer (JCOG1302A)

10.1007/s10120-017-0701-1 · 2018 · External reference

Protocol Digest of a Phase III Trial to Evaluate the Efficacy of Preoperative Chemotherapy With S‐1 Plus Oxaliplatin Followed by D2 Gastrectomy With Postoperative S‐1 in Locally Advanced Gastric Cancer: Japan Clinical Oncology Group Study JCOG1509 (NAGISA Trial)

10.1093/jjco/hyac154 · 2023 · External reference

Japanese Gastric Cancer Treatment Guidelines 2010 (ver. 3)

10.1007/s10120-011-0042-4 · 2011 · External reference

Japanese Classification of Gastric Carcinoma: 3rd English Edition

10.1007/s10120-011-0041-5 · 2011 · External reference

Prognostic Performance of Preoperative Staging: Assessed by Using Multidetector Computed Tomography‐Between the New Clinical Classification and the Pathological Classification in the Eighth American Joint Committee on Cancer Classification for Gastric Carcinoma

10.1245/s10434-019-07845-3 · 2020 · External reference

Impact of Clinical Tumor‐Node‐Metastasis Staging on Survival in Gastric Carcinoma Patients Receiving Surgery

10.1007/s10120-016-0637-x · 2017 · External reference

Radiological Criteria for Selecting Candidates for Neoadjuvant Chemotherapy for Gastric Cancer: An Exploratory Analysis From the PRODIGY Study

10.1007/s10120-021-01243-z · 2022 · External reference

Pan‐Asian Adapted ESMO Clinical Practice Guidelines for the Diagnosis, Treatment and Follow‐Up of Patients With Gastric Cancer

10.1016/j.esmoop.2023.102226 · 2024 · External reference

Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer

10.1056/nejmoa2503701 · 2025 · External reference

Addition of Docetaxel to Oral Fluoropyrimidine Improves Efficacy in Patients With Stage III Gastric Cancer: Interim Analysis of JACCRO GC‐07, a Randomized Controlled Trial

10.1200/jco.18.01138 · 2019 · External reference